Literature DB >> 22447658

Polo-like kinase 1, on the rise from cell cycle regulation to prostate cancer development.

Jijing Luo1, Xiaoqi Liu.   

Abstract

Polo-like kinase 1 (Plk1), a well-characterized member of serine/threonine kinases Plk family, has been shown to play pivotal roles in mitosis and cytokinesis in eukaryotic cells. Recent studies suggest that Plk1 not only controls the process of mitosis and cytokinesis, but also, going beyond those previously described functions, plays critical roles in DNA replication and Pten null prostate cancer initiation. In this review, we briefly summarize the functions of Plk1 in mitosis and cytokinesis, and then mainly focus on newly discovered functions of Plk1 in DNA replication and in Pten-null prostate cancer initiation. Furthermore, we briefly introduce the architectures of human and mouse prostate glands and the possible roles of Plk1 in human prostate cancer development. And finally, the newly chemotherapeutic development of small-molecule Plk1 inhibitors to target Plk1 in cancer treatment and their translational studies are also briefly reviewed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22447658      PMCID: PMC4875424          DOI: 10.1007/s13238-012-2020-y

Source DB:  PubMed          Journal:  Protein Cell        ISSN: 1674-800X            Impact factor:   14.870


  154 in total

1.  Late mitotic failure in mice lacking Sak, a polo-like kinase.

Authors:  J W Hudson; A Kozarova; P Cheung; J C Macmillan; C J Swallow; J C Cross; J W Dennis
Journal:  Curr Biol       Date:  2001-03-20       Impact factor: 10.834

Review 2.  Mechanisms of prostate cancer initiation and progression.

Authors:  Beatrice S Knudsen; Valera Vasioukhin
Journal:  Adv Cancer Res       Date:  2010       Impact factor: 6.242

Review 3.  Polo-like kinases: conservation and divergence in their functions and regulation.

Authors:  Vincent Archambault; David M Glover
Journal:  Nat Rev Mol Cell Biol       Date:  2009-04       Impact factor: 94.444

Review 4.  Polo-like kinases: a team that plays throughout mitosis.

Authors:  D M Glover; I M Hagan; A A Tavares
Journal:  Genes Dev       Date:  1998-12-15       Impact factor: 11.361

5.  Polo-like kinase 1 phosphorylation of G2 and S-phase-expressed 1 protein is essential for p53 inactivation during G2 checkpoint recovery.

Authors:  X Shawn Liu; Hongchang Li; Bing Song; Xiaoqi Liu
Journal:  EMBO Rep       Date:  2010-06-25       Impact factor: 8.807

6.  Phosphorylation of the cytokinesis regulator ECT2 at G2/M phase stimulates association of the mitotic kinase Plk1 and accumulation of GTP-bound RhoA.

Authors:  F Niiya; T Tatsumoto; K S Lee; T Miki
Journal:  Oncogene       Date:  2006-02-09       Impact factor: 9.867

7.  The small-molecule inhibitor BI 2536 reveals novel insights into mitotic roles of polo-like kinase 1.

Authors:  Péter Lénárt; Mark Petronczki; Martin Steegmaier; Barbara Di Fiore; Jesse J Lipp; Matthias Hoffmann; Wolfgang J Rettig; Norbert Kraut; Jan-Michael Peters
Journal:  Curr Biol       Date:  2007-02-08       Impact factor: 10.834

Review 8.  Polo-like kinases and oncogenesis.

Authors:  Frank Eckerdt; Juping Yuan; Klaus Strebhardt
Journal:  Oncogene       Date:  2005-01-10       Impact factor: 9.867

9.  Adaptation to the ionizing radiation-induced G2 checkpoint occurs in human cells and depends on checkpoint kinase 1 and Polo-like kinase 1 kinases.

Authors:  Randi G Syljuåsen; Sanne Jensen; Jiri Bartek; Jiri Lukas
Journal:  Cancer Res       Date:  2006-11-01       Impact factor: 12.701

10.  Selectivity-determining residues in Plk1.

Authors:  Michael Kothe; Darcy Kohls; Simon Low; Rocco Coli; Glen R Rennie; Frederic Feru; Cyrille Kuhn; Yuan-Hua Ding
Journal:  Chem Biol Drug Des       Date:  2007-11-13       Impact factor: 2.817

View more
  14 in total

Review 1.  Molecular classification of prostate cancer progression: foundation for marker-driven treatment of prostate cancer.

Authors:  Christopher J Logothetis; Gary E Gallick; Sankar N Maity; Jeri Kim; Ana Aparicio; Eleni Efstathiou; Sue-Hwa Lin
Journal:  Cancer Discov       Date:  2013-06-28       Impact factor: 39.397

2.  Plk1 promotes the migration of human lung adenocarcinoma epithelial cells via STAT3 signaling.

Authors:  Weijuan Yan; Huijie Yu; Wei Li; Fengsheng Li; Sinian Wang; Nan Yu; Qisheng Jiang
Journal:  Oncol Lett       Date:  2018-09-14       Impact factor: 2.967

3.  Nek9 regulates spindle organization and cell cycle progression during mouse oocyte meiosis and its location in early embryo mitosis.

Authors:  Shang-Wu Yang; Chen Gao; Lei Chen; Ya-Li Song; Jin-Liang Zhu; Shu-Tao Qi; Zong-Zhe Jiang; Zhong-Wei Wang; Fei Lin; Hao Huang; Fu-Qi Xing; Qing-Yuan Sun
Journal:  Cell Cycle       Date:  2012-11-16       Impact factor: 4.534

4.  PLK1 and HOTAIR Accelerate Proteasomal Degradation of SUZ12 and ZNF198 during Hepatitis B Virus-Induced Liver Carcinogenesis.

Authors:  Hao Zhang; Ahmed Diab; Huitao Fan; Saravana Kumar Kailasam Mani; Ronald Hullinger; Philippe Merle; Ourania Andrisani
Journal:  Cancer Res       Date:  2015-04-08       Impact factor: 12.701

5.  Abortive cell cycle events in the brains of scrapie-infected hamsters with remarkable decreases of PLK3/Cdc25C and increases of PLK1/cyclin B1.

Authors:  Hui Wang; Chan Tian; Yin Xu; Wu-Ling Xie; Jin Zhang; Bao-Yun Zhang; Ke Ren; Ke Wang; Cao Chen; Shao-Bin Wang; Qi Shi; Qi-Xiang Shao; Xiao-Ping Dong
Journal:  Mol Neurobiol       Date:  2013-04-27       Impact factor: 5.590

6.  Scytonemin inhibits cell proliferation and arrests cell cycle through downregulating Plk1 activity in multiple myeloma cells.

Authors:  Guojun Zhang; Zhe Zhang; Zhuogang Liu
Journal:  Tumour Biol       Date:  2013-04-13

7.  Polo-like kinase 1 is overexpressed in renal cancer and participates in the proliferation and invasion of renal cancer cells.

Authors:  Guojun Zhang; Zhe Zhang; Zhuogang Liu
Journal:  Tumour Biol       Date:  2013-03-14

8.  Identification of candidate miRNA biomarkers from miRNA regulatory network with application to prostate cancer.

Authors:  Wenyu Zhang; Jin Zang; Xinhua Jing; Zhandong Sun; Wenying Yan; Dongrong Yang; Bairong Shen; Feng Guo
Journal:  J Transl Med       Date:  2014-03-11       Impact factor: 5.531

9.  Polo-like kinase 1 induces epithelial-to-mesenchymal transition and promotes epithelial cell motility by activating CRAF/ERK signaling.

Authors:  Jianguo Wu; Andrei I Ivanov; Paul B Fisher; Zheng Fu
Journal:  Elife       Date:  2016-03-22       Impact factor: 8.140

10.  Increased Expression of Phosphorylated Polo-Like Kinase 1 and Histone in Bypass Vein Graft and Coronary Arteries following Angioplasty.

Authors:  Swastika Sur; Vicki J Swier; Mohamed M Radwan; Devendra K Agrawal
Journal:  PLoS One       Date:  2016-01-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.